January 25, 2018 / 9:20 PM / 6 months ago

BRIEF-Five Prime Therapeutics Announces $25 Mln Payment By Bristol-Myers Squibb

Jan 25 (Reuters) - Five Prime Therapeutics Inc:

* FIVE PRIME THERAPEUTICS ANNOUNCES $25 MILLION PAYMENT BY BRISTOL-MYERS SQUIBB FOR CABIRALIZUMAB DEVELOPMENT MILESTONE

* FIVE PRIME THERAPEUTICS INC SAYS MILESTONE WAS TRIGGERED BY INITIATION OF A MULTI-ARM PHASE 2 CLINICAL TRIAL SPONSORED BY BRISTOL-MYERS SQUIBB Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below